Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

9504	Companies
186528	Keywords
118774	Articles
99829	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 09/05/2024 at 14:30, 1 year 3 months ago

Jaguar Health Celebrates National Service Dog Month: With its Supportive Cancer Care Drugs, Jaguar is Dedicated to the Health and Wellbeing of People and Dogs
Jaguar Health's Canalevia-CA1 drug receives FDA conditional approval for chemotherapy-induced diarrhea treatment in dogs, making it the first approved treatment for this condition

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Dogs
BRIEF

published on 09/04/2024 at 16:05, 1 year 3 months ago

Jaguar Health Announces Key Commercial and Development Milestones

Crofelemer Clinical Trials Jaguar Health Rare Diseases Gelclair®
BRIEF

published on 09/04/2024 at 16:05, 1 year 3 months ago

Jaguar Health annonce des étapes clés en matière de développement et de commercialisation

Crofelemer Essais Cliniques Maladies Rares Santé Jaguar Gelclair®
PRESS RELEASE

published on 09/04/2024 at 16:00, 1 year 3 months ago

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details

Jaguar Health Inc. Rare Diseases Gelclair Launch Crofelemer Trials Lisa Conte Interview
BRIEF

published on 08/27/2024 at 16:05, 1 year 3 months ago

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

Crofelemer Short Bowel Syndrome Patent Jaguar Health Intellectual Property
BRIEF

published on 08/27/2024 at 16:05, 1 year 3 months ago

Un brevet délivré en Jordanie renforce la protection de la propriété intellectuelle de Jaguar Health dans le traitement du syndrome de l'intestin court (SIC)

Crofelemer Propriété Intellectuelle Brevet Santé Jaguar Syndrome De L'intestin Court
PRESS RELEASE

published on 08/27/2024 at 16:00, 1 year 3 months ago

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Jaguar Health, Inc. announces issuance of new patent for crofelemer to treat rare diseases like SBS and MVID, enhancing IP protection. Independent studies supported in US, EU, and MENA regions

Crofelemer Patent Jaguar Health Rare Diseases SBS
BRIEF

published on 08/20/2024 at 16:05, 1 year 3 months ago

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award

Jaguar Health Magdalena Biosciences Alzheimer's Award Eduardo Zimmer Botanical Drugs
BRIEF

published on 08/20/2024 at 16:05, 1 year 3 months ago

Magdalena Biosciences, collaboratrice clé de la joint-venture Jaguar Health, reçoit le prestigieux prix de l'Alzheimer's Association

Santé Jaguar Eduardo Zimmer Biosciences De Magdalena Prix Alzheimer Médicaments À Base De Plantes
PRESS RELEASE

published on 08/20/2024 at 16:00, 1 year 3 months ago

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
Jaguar Health announces Eduardo Zimmer as 2024 Blas Frangione Early Career Achievement Award recipient for work with Magdalena Biosciences on plant-based mental health medicines

Mental Health Jaguar Health Magdalena Biosciences Plant-based Medicines Eduardo Zimmer

Accesswire

Published on 12/10/2025 at 19:00, 6 minutes ago

SMX at NAFRA: A Signal to Recyclers That Industrial Traceability Is Finally Arriving
Published on 12/10/2025 at 17:30, 1 hour 36 minutes ago

SMX: Industry Validation Becomes Industry Visibility
Published on 12/10/2025 at 16:20, 2 hours 46 minutes ago

SMX Moves Past Proof and Into the NAFRA Room Where Implementation Begins
Published on 12/10/2025 at 15:10, 3 hours 56 minutes ago

Nano One Closes $6.96 Million Overnight Marketed Offering
Published on 12/10/2025 at 15:00, 4 hours 6 minutes ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs

View all ACCESSWIRE

EQS Group

Published on 12/10/2025 at 18:44, 22 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/10/2025 at 18:29, 37 minutes ago

POS-Transaction in Own Shares
Published on 12/10/2025 at 18:00, 1 hour 6 minutes ago

ROCTOOL: Signature d’une commande stratégique de 6 M€ dans l’aéronautique et la défense
Published on 12/10/2025 at 18:00, 1 hour 6 minutes ago

Private Equity Holding AG: Net Asset Value as of November 30, 2025
Published on 12/10/2025 at 17:28, 1 hour 37 minutes ago

Amundi Physical Metals plc: Final Terms

Les Echos

Published on 12/10/2025 at 18:55, 11 minutes ago

Half-year results for 2025/2026 and availability of the half-year financial report
Published on 12/10/2025 at 18:55, 11 minutes ago

Résultats semestriels 2025/2026 et mise à disposition du rapport financier semestriel
Published on 12/10/2025 at 18:20, 46 minutes ago

Groupe ADP 2027-2034 Economic Regulation Agreement (ERA) proposal
Published on 12/10/2025 at 18:20, 46 minutes ago

Groupe ADP - Projet de contrat de régulation économique 2027-2034 du Groupe ADP
Published on 12/10/2025 at 17:45, 1 hour 21 minutes ago

Innelec : Nomination de Julien Peyrafitte en tant que Président du Directoire d’Innelec Multimedia.

View all LES ECHOS COMFI WIRE